Jenest, M.A.; Fugit, R.V.; Wright, J.; Bessesen, M.T.; Kon, S.E.
Impact of a Three-Strain Lactobacilli Probiotic (BioK+) on Incidence of Hospital-Onset Clostridioides difficile: A Retrospective Observational Cohort Study. Antibiotics 2025, 14, 1225.
https://doi.org/10.3390/antibiotics14121225
AMA Style
Jenest MA, Fugit RV, Wright J, Bessesen MT, Kon SE.
Impact of a Three-Strain Lactobacilli Probiotic (BioK+) on Incidence of Hospital-Onset Clostridioides difficile: A Retrospective Observational Cohort Study. Antibiotics. 2025; 14(12):1225.
https://doi.org/10.3390/antibiotics14121225
Chicago/Turabian Style
Jenest, Matthew A., Randolph V. Fugit, Jason Wright, Mary T. Bessesen, and Shelley E. Kon.
2025. "Impact of a Three-Strain Lactobacilli Probiotic (BioK+) on Incidence of Hospital-Onset Clostridioides difficile: A Retrospective Observational Cohort Study" Antibiotics 14, no. 12: 1225.
https://doi.org/10.3390/antibiotics14121225
APA Style
Jenest, M. A., Fugit, R. V., Wright, J., Bessesen, M. T., & Kon, S. E.
(2025). Impact of a Three-Strain Lactobacilli Probiotic (BioK+) on Incidence of Hospital-Onset Clostridioides difficile: A Retrospective Observational Cohort Study. Antibiotics, 14(12), 1225.
https://doi.org/10.3390/antibiotics14121225